153 related articles for article (PubMed ID: 31184893)
1. Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease.
Ma Y; Li L; He S; Shang C; Sun Y; Liu N; Meek TD; Wang Y; Shang L
J Med Chem; 2019 Jul; 62(13):6146-6162. PubMed ID: 31184893
[TBL] [Abstract][Full Text] [Related]
2. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
[TBL] [Abstract][Full Text] [Related]
3. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
[TBL] [Abstract][Full Text] [Related]
4. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
[TBL] [Abstract][Full Text] [Related]
5. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of α-keto amides as enterovirus 71 3C protease inhibitors.
Zeng D; Ma Y; Zhang R; Nie Q; Cui Z; Wang Y; Shang L; Yin Z
Bioorg Med Chem Lett; 2016 Apr; 26(7):1762-6. PubMed ID: 26916437
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
[TBL] [Abstract][Full Text] [Related]
8. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.
Tan YW; Ang MJ; Lau QY; Poulsen A; Ng FM; Then SW; Peng J; Hill J; Hong WJ; Chia CS; Chu JJ
Sci Rep; 2016 Sep; 6():33663. PubMed ID: 27645381
[TBL] [Abstract][Full Text] [Related]
10. Target-guided screening of fragments (TGSOF) in the discovery of inhibitors against EV-A71 3C protease.
Fu S; Nie Q; Ma Y; Song P; Ren X; Luo C; Shang L; Yin Z
Chem Commun (Camb); 2018 Mar; 54(23):2890-2893. PubMed ID: 29497732
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of irreversible inhibitors of foot-and-mouth disease virus 3C protease.
Roqué Rosell NR; Mokhlesi L; Milton NE; Sweeney TR; Zunszain PA; Curry S; Leatherbarrow RJ
Bioorg Med Chem Lett; 2014 Jan; 24(2):490-4. PubMed ID: 24374278
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
[TBL] [Abstract][Full Text] [Related]
13. Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir.
Wu C; Cai Q; Chen C; Li N; Peng X; Cai Y; Yin K; Chen X; Wang X; Zhang R; Liu L; Chen S; Li J; Lin T
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):866-71. PubMed ID: 23633597
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C protease.
Johnson TO; Hua Y; Luu HT; Brown EL; Chan F; Chu SS; Dragovich PS; Eastman BW; Ferre RA; Fuhrman SA; Hendrickson TF; Maldonado FC; Matthews DA; Meador JW; Patick AK; Reich SH; Skalitzky DJ; Worland ST; Yang M; Zalman LS
J Med Chem; 2002 May; 45(10):2016-23. PubMed ID: 11985469
[TBL] [Abstract][Full Text] [Related]
15. 3D-quantitative structure-activity relationship study for the design of novel enterovirus A71 3C protease inhibitors.
Nie Q; Xu X; Zhang Q; Ma Y; Yin Z; Shang L
Chem Biol Drug Des; 2018 Oct; 92(4):1750-1762. PubMed ID: 29877617
[TBL] [Abstract][Full Text] [Related]
16. Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro.
Cao Z; Ding Y; Ke Z; Cao L; Li N; Ding G; Wang Z; Xiao W
PLoS One; 2016; 11(2):e0148693. PubMed ID: 26870944
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
18. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
Wanga QM; Chen SH
Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
[TBL] [Abstract][Full Text] [Related]
19. Phenylthiomethyl Ketone-Based Fragments Show Selective and Irreversible Inhibition of Enteroviral 3C Proteases.
Schulz R; Atef A; Becker D; Gottschalk F; Tauber C; Wagner S; Arkona C; Abdel-Hafez AA; Farag HH; Rademann J; Wolber G
J Med Chem; 2018 Feb; 61(3):1218-1230. PubMed ID: 29328649
[TBL] [Abstract][Full Text] [Related]
20. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
